do-me/EUR-LEX huggingface dataset:
Case T-486/20 R: Order of the President of the General Court of 12 April 2021 — Kühne v Parliament (Application for interim relief — Civil service — Officials — Reassignment — Application for suspension of operation of a measure — Application for interim measures — No prima facie case)
Date: 2021-04-12
Institutions: General Court
Subjects: European official, reassignment








C_2021242EN.01004701.xml










21.6.2021   


EN


Official Journal of the European Union


C 242/47






Order of the President of the General Court of 12 April 2021 — Kühne v Parliament
(Case T-486/20 R)
(Application for interim relief - Civil service - Officials - Reassignment - Application for suspension of operation of a measure - Application for interim measures - No prima facie case)
(2021/C 242/67)
Language of the case: German

Parties


Applicant: Verena Kühne (Berlin, Germany) (represented by: O. Schmechel, lawyer)

Defendant: European Parliament (represented by: L. Darie and B. Schäfer, acting as Agents)

Re:

APPLICATION under Articles 278 and 279 TFEU for the grant of interim measures (i) suspending the operation of the decision of the Parliament of 2 July 2020 reassigning the applicant to the European Parliament’s liaison office in Luxembourg (Luxembourg) with effect from 1 September 2020 and (ii) maintaining the applicant’s employment in her current post at the European Parliament’s liaison office in Berlin or other measures appropriate for maintaining the status quo in the interim pending the decision on the substance.

Operative part of the order







1.


The application for interim measures is rejected.










2.


The order of 4 September 2020, Kühne v Parliament (T-468/20 R), is revoked.










3.


The costs are reserved.
Case T-194/21: Action brought on 12 April 2021 — Fidia farmaceutici v EUIPO — Stelis Biopharma (HYALOSTEL ONE)
Date: 2021-04-12
Institutions: General Court
Subjects: EU trade mark, dietary product, pharmaceutical product, registered trade mark, trade-mark law








C_2021217EN.01005701.xml










7.6.2021   


EN


Official Journal of the European Union


C 217/57






Action brought on 12 April 2021 — Fidia farmaceutici v EUIPO — Stelis Biopharma (HYALOSTEL ONE)
(Case T-194/21)
(2021/C 217/72)
Language of the case: English

Parties


Applicant: Fidia farmaceutici SpA (Abano Terme, Italy) (represented by: R. Kunz-Hallstein and H. Kunz-Hallstein, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Stelis Biopharma ltd. (Karnataka, India)

Details of the proceedings before EUIPO


Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: International registration designating the European Union in respect of the figurative HYALOSTEL ONE mark — International registration designating the European Union No 1 399 649

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 27 January 2021 in Case R 831/2020-5

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


order EUIPO to pay the costs, in the alternative, if the other party before the Board of Appeal intervenes, order EUIPO and the intervener jointly and severally to pay the costs.





Pleas in law







—


Infringement of Article 165(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council and Articles 32(f) and 39(5) of Commission Delegated Regulation (EU) 2018/625;










—


Infringement of the right to be heard and the obligation to state reasons pursuant Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
Euro exchange rates (Source: reference exchange rate published by the ECB.) 9 April 2021 2021/C 125/02
Date: 2021-04-12
Institutions: European Commission
Subjects: euro, exchange rate, money








C_2021125EN.01000201.xml










12.4.2021   


EN


Official Journal of the European Union


C 125/2






Euro exchange rates (1)

9 April 2021
(2021/C 125/02)

1 euro =











 


Currency


Exchange rate




USD


US dollar


1,1888 




JPY


Japanese yen


130,42 




DKK


Danish krone


7,4372 




GBP


Pound sterling


0,86658 




SEK


Swedish krona


10,1725 




CHF


Swiss franc


1,1010 




ISK


Iceland króna


151,90 




NOK


Norwegian krone


10,1130 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


25,945 




HUF


Hungarian forint


357,97 




PLN


Polish zloty


4,5392 




RON


Romanian leu


4,9198 




TRY


Turkish lira


9,6903 




AUD


Australian dollar


1,5579 




CAD


Canadian dollar


1,4950 




HKD


Hong Kong dollar


9,2470 




NZD


New Zealand dollar


1,6860 




SGD


Singapore dollar


1,5941 




KRW


South Korean won


1 331,28 




ZAR


South African rand


17,3100 




CNY


Chinese yuan renminbi


7,7934 




HRK


Croatian kuna


7,5755 




IDR


Indonesian rupiah


17 354,52 




MYR


Malaysian ringgit


4,9157 




PHP


Philippine peso


57,764 




RUB


Russian rouble


91,8152 




THB


Thai baht


37,388 




BRL


Brazilian real


6,6641 




MXN


Mexican peso


23,9374 




INR


Indian rupee


88,8145 






(1)  Source: reference exchange rate published by the ECB.
Non-opposition to a notified concentration (Case M.10163 — United Internet/Morgan Stanley/Tele Columbus) (Text with EEA relevance) 2021/C 365/01
Date: 2021-04-12
Institutions: Directorate-General for Competition, European Commission
Subjects: Internet access provider, cable distribution, economic concentration, financial services, investment bank, investment company, merger control, multimedia, telecommunications








C_2021365EN.01000101.xml










10.9.2021   


EN


Official Journal of the European Union


C 365/1






Non-opposition to a notified concentration
(Case M.10163 — United Internet/Morgan Stanley/Tele Columbus)
(Text with EEA relevance)
(2021/C 365/01)
On 12 April 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10163. EUR-Lex is the online access to European law.






(1)  OJ L 24, 29.1.2004, p. 1.